Our Values
NOVAIR is working for a world that breathes better by reinventing access to the air gases essential to human life and activity, for everyone, everywhere, and in a sustainable way.
NOVAIR liberates and enables every hospital and every industry, whether in densely populated or isolated areas, to manage its medical oxygen or nitrogen supply autonomously.
At NOVAIR, we innovate every day to ensure that everyone, everywhere in the world, has access to the best air while preserving it.
NOVAIR is headquartered in France and has several subsidiaries in Europe - Italy, Germany - and the United States.
Three plants and R&D centers spread over 17,500 m2 design, manufacture, and ship NOVAIR solutions worldwide.
The company employs over 200 people worldwide and operates in more than 150 countries via affiliated and trained distributors and partners.
NOVAIR service teams also provide a direct local and regional presence in many countries in Africa, Asia, and South America.
PSA (Pressure Swing Adsorption) technology separates gases from air using a molecular sieve capable of adsorbing nitrogen/oxygen under pressure.
An exclusive NOVAIR know-how, DS-PSA (Double-Stage PSA) is based on a two-stage PSA molecular separation process.
The latest NOVAIR technology, the R-PSA is based on an innovative rotary PSA process implemented in a minimum of space.
Modular PSA generators are composed of multiple molecular sieve modules for optimum flexibility.
The combination of PSA and low pressure for maximum energy efficiency.
NOVAIR's Vacuum PSA is designed for sites and facilities requiring the highest oxygen production capacities.